Amgen Inc. (AMGN)

Last Closing Price: 253.65 (2023-01-27)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Amgen Inc. (AMGN) had Net Income of $2.14B for the most recently reported fiscal quarter, ending 2022-09-30.

Figures for fiscal quarter ending 2022-09-30
Income Statement Financials
$6.65B
Net Income
$2.14B
$1.59B
$5.06B
$3.99B
$2.66B
$-268.00M
$2.39B
$2.39B
$2.14B
$2.14B
$2.14B
$2.14B
$2.66B
$3.50B
535.00M
538.00M
$4.01
$3.98
Balance Sheet Financials
$24.06B
$5.19B
$39.64B
$63.70B
$14.33B
$37.16B
$45.72B
$60.05B
$3.65B
$-24.46B
$3.65B
533.50M
Cash Flow Statement Financials
$7.07B
$-2.57B
$-2.99B
$7.99B
$9.50B
$1.51B
--
$-3.16B
--
Fundamental Metrics & Ratios
1.68
--
--
0.91
10.60
76.13%
39.99%
39.99%
--
35.96%
32.22%
$6.48B
--
--
--
0.10
0.33
1.25
72.06
58.66%
-8.76%
3.36%
5.25%
$6.85
$12.04
$13.14